Arvest Trust CO N A Viatris Inc Transaction History

Arvest Trust CO N A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $28,539 - $33,777	-2,976 Reduced 1.43%	205,363 $2.02 Million
Q2 2023 Aug 15, 2023	SELL	$9.02 - $10.29 $94,971 - $108,343	-10,529 Reduced 4.81%	208,339 $2.08 Million
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $168,350 - $224,345	18,299 Added 9.12%	218,868 $2.11 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $268,785 - $356,325	30,824 Added 18.16%	200,569 $2.23 Million
Q3 2022 Nov 07, 2022	BUY	$8.48 - $11.13 $425,204 - $558,080	50,142 Added 41.92%	169,745 $1.45 Million
Q2 2022 Aug 11, 2022	BUY	$9.95 - $12.27 $314,270 - $387,547	31,585 Added 35.88%	119,603 $1.25 Million
Q1 2022 May 04, 2022	BUY	$9.81 - $15.4 $182,152 - $285,947	18,568 Added 26.74%	88,018 $958,000
Q4 2021 Mar 08, 2022	BUY	$12.09 - $14.68 $839,650 - $1.02 Million	69,450 New	69,450 $940,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.4B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Arvest Trust CO N A, based on Form 13F filings with the SEC.

Stay updated on Arvest Trust CO N A with notifications on news.